Shu-Mei Yang Selected Research

cuminaldehyde

5/2016	Cuminaldehyde from Cinnamomum verum Induces Cell Death through Targeting Topoisomerase 1 and 2 in Human Colorectal Adenocarcinoma COLO 205 Cells.
1/2016	Molecular Mechanism of Cinnamomum verum Component Cuminaldehyde Inhibits Cell Growth and Induces Cell Death in Human Lung Squamous Cell Carcinoma NCI-H520 Cells In Vitro and In Vivo.
1/2016	Discovery of a Novel Anti-Cancer Agent Targeting Both Topoisomerase I & II as Well as Telomerase Activities in Human Lung Adenocarcinoma A549 Cells In Vitro and In Vivo: Cinnamomum verum Component Cuminaldehyde.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shu-Mei Yang Research Topics

Disease

7	Carcinogenesis 02/2021 - 01/2012
5	Neoplasms (Cancer) 05/2016 - 06/2005
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2018 - 01/2015
2	Lung Neoplasms (Lung Cancer) 08/2022 - 06/2015
2	Inflammation (Inflammations) 02/2021 - 12/2010
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017 - 01/2016
2	Adenocarcinoma 05/2016 - 01/2016
2	Stroke (Strokes) 01/2016 - 02/2015
2	Adenocarcinoma of Lung 01/2016 - 06/2005
1	Acute Coronary Syndrome 01/2022
1	Atrial Fibrillation 01/2022
1	Intracranial Hemorrhages (Intracranial Hemorrhage) 01/2022
1	Hemorrhage 01/2022
1	Myocardial Infarction 01/2022
1	Thrombosis (Thrombus) 01/2022
1	Epilepsy (Aura) 10/2021
1	Central Nervous System Diseases (CNS Diseases) 10/2021
1	Infections 02/2021
1	Lung Injury 02/2021
1	Tendon Injuries 01/2020
1	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2020
1	Tendinopathy (Tendonitis) 01/2020
1	Alzheimer Disease (Alzheimer's Disease) 12/2018
1	Amyloid Plaque 12/2018
1	Obesity 01/2018
1	Elephantiasis 01/2016
1	Rheumatic Diseases (Rheumatism) 01/2016
1	Lymphadenopathy 01/2016
1	Skin Diseases (Skin Disease) 01/2016
1	Virus Diseases (Viral Diseases) 01/2016
1	Dyspepsia (Indigestion) 01/2016
1	Neoplasm Metastasis (Metastasis) 06/2015
1	Chronic Disease (Chronic Diseases) 02/2015
1	Sunburn 01/2012
1	Skin Neoplasms (Skin Cancer) 01/2012
1	Wounds and Injuries (Trauma) 01/2011
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2011
1	Fibrosis (Cirrhosis) 01/2011

Drug/Important Bio-Agent (IBA)

5	Biomarkers (Surrogate Marker)IBA 01/2017 - 01/2012
4	ArsenicIBA 01/2018 - 01/2007
3	Type I DNA Topoisomerases (Topoisomerase I)IBA 01/2017 - 01/2016
3	cuminaldehydeIBA 05/2016 - 01/2016
2	2-methoxycinnamaldehydeIBA 01/2017 - 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 08/2022
1	Docetaxel (Taxotere)FDA Link 08/2022
1	MicroRNAs (MicroRNA)IBA 08/2022
1	Annexin A5IBA 08/2022
1	Nicotine FDA Link 08/2022
1	AnticoagulantsIBA 01/2022
1	theasinensin AIBA 01/2022
1	Vitamin K FDA Link 01/2022
1	N(4)-oleylcytosine arabinosideIBA 01/2022
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022
1	gastrodinIBA 10/2021
1	Pilocarpine (Ocusert)FDA LinkGeneric 10/2021
1	LithiumIBA 10/2021
1	Stromal Interaction Molecule 1IBA 02/2021
1	InflammasomesIBA 02/2021
1	tributyl phosphate (TBP)IBA 01/2020
1	polyglutamineIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020
1	Hyaluronic Acid (Hyaluronan)IBA 01/2020
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2020
1	PolydeoxyribonucleotidesIBA 01/2020
1	TATA-Box Binding Protein (TATA-Binding Protein)IBA 01/2020
1	Amyloid (Amyloid Fibrils)IBA 12/2018
1	AdiponectinIBA 01/2018
1	Telomerase (Telomerase Reverse Transcriptase)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	Pharmaceutical PreparationsIBA 01/2016
1	MethyltransferasesIBA 01/2016
1	Plant ExtractsIBA 01/2016
1	EnzymesIBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 06/2015
1	Tyrosine (L-Tyrosine)FDA Link 06/2015
1	Cytoskeletal ProteinsIBA 06/2015
1	CalciumIBA 06/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2015
1	Hypnotics and Sedatives (Sedatives)IBA 02/2015
1	Monoclonal AntibodiesIBA 01/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2015
1	CurcuminIBA 01/2012
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 01/2012
1	Nuclear Antigens (Extractable Nuclear Antigens)IBA 01/2012
1	Pyrimidine DimersIBA 01/2012
1	DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA 01/2012
1	Bleomycin (Blenoxane)FDA LinkGeneric 01/2011
1	Moclobemide (Arima)IBA 01/2011
1	Interleukin-6 (Interleukin 6)IBA 01/2011
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2010

Therapy/Procedure

3	Therapeutics 01/2022 - 02/2021
1	Stents 01/2022
1	Percutaneous Coronary Intervention 01/2022
1	Microbubbles 10/2021
1	Prolotherapy 01/2020
1	Conservative Treatment 01/2020
1	Extracorporeal Shockwave Therapy 01/2020
1	Ultrasonic Therapy 01/2020
1	Ligation 06/2015
1	Immunotherapy 01/2015